Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair
TPST•Tempest Therapeutics appointed Nancy Freda-Smith to its board and named her audit committee chair. She most recently served as chief audit and risk officer at Ralph Lauren and previously was a managing director at Deloitte & Touche LLP.
1. Board appointment
Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors, where she will chair the audit committee. She most recently served as chief audit and risk officer at Ralph Lauren and earlier held a managing director role at Deloitte & Touche LLP.
